OBJECTIVE: There are few studies on the natural history of milk allergy. Most are single-site and not longitudinal, and these have not identified a means for early prediction of outcomes. METHODS: Children aged 3 to 15 months were enrolled in an observational study with either (1) a convincing history of egg allergy, milk allergy, or both with a positive skin prick test (SPT) response to the trigger food and/or (2) moderate-to-severe atopic dermatitis (AD) and a positive SPT response to milk or egg. Children enrolled with a clinical history of milk allergy were followed longitudinally, and resolution was established by means of successful ingestion. RESULTS: The cohort consists of 293 children, of whom 244 were given a diagnosis of milk allergy at baseline. Milk allergy has resolved in 154 (52.6%) subjects at a median age of 63 months and a median age at last follow-up of 66 months. Baseline characteristics that were most predictive of resolution included milk-specific IgE level, milk SPT wheal size, and AD severity (all P < .001). Baseline milk-specific IgG4 level and milk IgE/IgG4 ratio were not predictive of resolution and neither was expression of cytokine-inducible SH2-containing protein, forkhead box protein 3, GATA3, IL-10, IL-4, IFN-γ, or T-bet by using real-time PCR in CD25-selected, casein-stimulated mononuclear cells. A calculator to estimate resolution probabilities using baseline milk IgE level, SPT response, and AD severity was devised for use in the clinical setting. CONCLUSIONS: In this cohort of infants with milk allergy, approximately one half had resolved over 66 months of follow-up. Baseline milk-specific IgE level, SPT wheal size, and AD severity were all important predictors of the likelihood of resolution.
OBJECTIVE: There are few studies on the natural history of milk allergy. Most are single-site and not longitudinal, and these have not identified a means for early prediction of outcomes. METHODS:Children aged 3 to 15 months were enrolled in an observational study with either (1) a convincing history of egg allergy, milk allergy, or both with a positive skin prick test (SPT) response to the trigger food and/or (2) moderate-to-severe atopic dermatitis (AD) and a positive SPT response to milk or egg. Children enrolled with a clinical history of milk allergy were followed longitudinally, and resolution was established by means of successful ingestion. RESULTS: The cohort consists of 293 children, of whom 244 were given a diagnosis of milk allergy at baseline. Milk allergy has resolved in 154 (52.6%) subjects at a median age of 63 months and a median age at last follow-up of 66 months. Baseline characteristics that were most predictive of resolution included milk-specific IgE level, milk SPT wheal size, and AD severity (all P < .001). Baseline milk-specific IgG4 level and milkIgE/IgG4 ratio were not predictive of resolution and neither was expression of cytokine-inducible SH2-containing protein, forkhead box protein 3, GATA3, IL-10, IL-4, IFN-γ, or T-bet by using real-time PCR in CD25-selected, casein-stimulated mononuclear cells. A calculator to estimate resolution probabilities using baseline milkIgE level, SPT response, and AD severity was devised for use in the clinical setting. CONCLUSIONS: In this cohort of infants with milk allergy, approximately one half had resolved over 66 months of follow-up. Baseline milk-specific IgE level, SPT wheal size, and AD severity were all important predictors of the likelihood of resolution.
Authors: Donald Y M Leung; Richard A Nicklas; James T Li; I Leonard Bernstein; Joann Blessing-Moore; Mark Boguniewicz; Jean A Chapman; David A Khan; David Lang; Rufus E Lee; Jay M Portnoy; Diane E Schuller; Sheldon L Spector; Stephen A Tilles Journal: Ann Allergy Asthma Immunol Date: 2004-09 Impact factor: 6.347
Authors: C García-Ara; T Boyano-Martínez; J M Díaz-Pena; F Martín-Muñoz; M Reche-Frutos; M Martín-Esteban Journal: J Allergy Clin Immunol Date: 2001-01 Impact factor: 10.793
Authors: Scott H Sicherer; Robert A Wood; Brian P Vickery; Stacie M Jones; Andrew H Liu; David M Fleischer; Peter Dawson; Lloyd Mayer; A Wesley Burks; Alexander Grishin; Donald Stablein; Hugh A Sampson Journal: J Allergy Clin Immunol Date: 2014-02 Impact factor: 10.793
Authors: Scott H Sicherer; Robert A Wood; Tamara T Perry; Stacie M Jones; Donald Y M Leung; Alice K Henning; Peter Dawson; A Wesley Burks; Robert Lindblad; Hugh A Sampson Journal: Allergy Date: 2019-07-15 Impact factor: 13.146
Authors: Anna Nowak-Węgrzyn; Kaitie Lawson; Madhan Masilamani; Jacob Kattan; H T Bahnson; Hugh A Sampson Journal: J Allergy Clin Immunol Pract Date: 2017-12-07
Authors: Rekha D Jhamnani; Samara Levin; Marjohn Rasooly; Kelly D Stone; Joshua D Milner; Celeste Nelson; Tom DiMaggio; Nina Jones; Anthony L Guerrerio; Pamela A Frischmeyer-Guerrerio Journal: J Allergy Clin Immunol Date: 2018-02-21 Impact factor: 10.793